Universal-Beteiligungs- und Servicegesellschaft
MLYS icon

Universal-Beteiligungs- und Servicegesellschaft’s Mineralys Therapeutics MLYS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$533K Buy
19,689
+7,692
+64% +$226K ﹤0.01% 1697
2025
Q4 		$435K Buy
+11,997
New +$481K ﹤0.01% 1754

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's MLYS Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Mineralys Therapeutics (MLYS) stake by 64% in Q1 2026, buying an estimated $226K and bringing the position to 19,689 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #1697.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in MLYS in Q4 2025 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 19,689 shares of Mineralys Therapeutics worth $533K as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 7,692 Mineralys Therapeutics shares in Q1 2026, an estimated $226K.
  • Mineralys Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1697 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Mineralys Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.